Do All Drugs Benefit From Therapeutic Drug Monitoring?

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 185 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Pharmacology for the Clinical Chemist: Therapeutic Drug Monitoring and Pharmacogenomics. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Pharmacology for the Clinical Chemist: Therapeutic Drug Monitoring and Pharmacogenomics (online CE course)
Do All Drugs Benefit From Therapeutic Drug Monitoring?

Can all drugs benefit from TDM? No, not when considering some drugs' mechanism of action and pharmacology. For TDM to be effective and valuable, one or more of the following should apply:
  • The effective concentration and toxic concentrations are well defined.
  • The pharmacokinetics of the drug are known to be variable.
  • The drug is given chronically.
  • There is the potential for drug-to-drug interactions.
  • The drug exhibits high protein binding.
  • The toxicity mimics the indication for the drug; toxicity may not be visible during an exam but will only be revealed with TDM.
  • The patient is pregnant, very young, or elderly.
  • Compliance or history with the drug is poor.
Unless criteria like these exist, monitoring the drug makes little sense. Penicillin, for example, is never measured in the serum. It has a wide therapeutic window, is not given chronically, has minimal toxicity, etc.